Kuros Biosciences AG (KURN.SW)

Switzerland · Healthcare · CHF

Key financials

ROE: 3.43%; 2025 (actual)
ROA: 2.25%; 2025 (actual)
Gross Margin: 88.6%; 2025 (actual)
Net Margin: 1.75%; 2025 (actual)
Total Assets: CHF 133,875.00K; 2025 (actual)
Net Income: CHF 2,551.00K; 2025 (actual)
Valuation: CHF 1,090,220.36K; 2025 (actual)
Stock Price: CHF 27.48; 2025 (actual)

Historical & projected performance

Reported figures and Equlion model projections for the next 5 years.

Metric	2025 (actual)	2026	2027	2028	2029	2030
ROE	3.43%	3.89%	4.42%	4.74%	4.98%	5.06%
Sector average	-19.57%	-18.86%	21.26%	45.9%	27.83%	13.61%
ROA	2.25%	2.36%	2.52%	2.6%	2.66%	2.67%
Sector average	-4.19%	-6.68%	-24.58%	1.77%	-29.44%	7.73%
Gross Margin	88.6%	88.6%	88.6%	88.6%

Amounts in CHF (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2025. Projections are model estimates, not investment advice.

Want the full financial forecast report for Kuros Biosciences AG? It covers the balance sheet, income statement and Equlion model projections.

Total Assets	CHF 133,875.00K	CHF 149,980.84K	CHF 164,848.22K	CHF 178,066.54K	CHF 191,256.92K	CHF 202,393.33K
Sector average	CHF 6,583,664.69K	CHF 7,029,775.91K	CHF 7,875,113.17K	CHF 8,842,325.96K	CHF 9,880,548.85K	CHF 10,888,357.41K

Net Income	CHF 2,551.00K	CHF 3,355.81K	CHF 3,966.49K	CHF 4,456.76K	CHF 4,918.73K	CHF 5,248.49K
Sector average	CHF 509,037.80K	CHF 497,738.03K	CHF 567,206.48K	CHF 655,953.18K	CHF 738,044.20K	CHF 795,142.15K

Valuation	CHF 1,090,220.36K	CHF 1,111,195.69K	CHF 1,131,649.38K	CHF 1,151,851.74K	CHF 1,171,882.18K	CHF 1,192,036.68K
Sector average	CHF 12,182,569.70K	CHF 13,169,956.24K	CHF 13,319,586.58K	CHF 13,502,659.68K	CHF 13,728,881.51K	CHF 13,908,079.25K

Stock Price	CHF 27.48	CHF 28.01	CHF 28.52	CHF 29.03	CHF 29.54	CHF 30.05
Sector average	CHF 102.74	CHF 98.77	CHF 102.59	CHF 107.21	CHF 112.19	CHF 115.32